srch

Research and review articles in medicinal chemistry and related drug discovery science. MedChemComm has now changed its name to RSC Medicinal Chemistry.

For more information about interference compounds see JB Baell and GA Holloway, J. Med. Chem. 2010, 53, 2719-2740. Computational studies Details of the types of computational studies that are suitable for publication in RSC Medicinal Chemistry are given in …

Oct 05, 2015 · Med. Chem. Commun., 2016, 7, 141-147 Permissions. Request permissions Syntheses and biological evaluations of highly functionalized hydroxamate containing and N ...

MedChemComm (in full: Medicinal Chemistry Communications) is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. Until December 2019, it was published monthly by the Royal Society of Chemistry in ...

Research and review articles in medicinal chemistry and related drug discovery science. MedChemComm has now changed its name to RSC Medicinal Chemistry. Editor-in-chief: Gerhard Ecker Time to first decision (with reviews): 32 days

A systematic analysis of atomic protein–ligand interactions in the PDB R. Ferreira de Freitas and M. Schapira, Med. Chem. Commun., 2017, 8, 1970 DOI: 10.1039/C7MD00381A This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided …

Call for Papers. New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science. ACS Medicinal Chemistry Letters , ACS Pharmacology & ...

MedChemComm (in full: Medicinal Chemistry Communications) is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. Until December 2019,

14.12.2021 · ChemMedChem publishes high-impact articles on medicinal chemistry and drug discovery, from small molecules to new modalities, showcasing the breadth of international research. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. Find out more.

MedChemComm (in full: Medicinal Chemistry Communications) is a peer-reviewed scientific journal publishing original (primary) research and review articles ...

Chem. Commun. Author(s): G Drakakis, G. Hendry, K Hanson, SC Brewerton, MJ Bodkin, DA Evans, G. Wheeler, M. Bender. Publication date: 2014 ...

Scientific Reviews & Chemical Communications is a renowned international journal for the discovery and broadcasting of breakthroughs on new avenues of ...

Med. Chem. Commun., 2011, 2, 396-401 Permissions. Request permissions Binding properties and biological characterization of new sugar-derived Ras ligands ...

Discovery of FtsZ inhibitors by virtual screening as antibacterial agents and study of the inhibition mechanism Med. Chem. Commun. (IF 3.597) Pub Date : 2021-11-15. Ruo-Lan Du, Ning Sun, Yik-Hong Fung, Yuan-Yuan Zheng, Yu-Wei Chen, Pak-Ho Chan, Wing-Leung Wong, Kwok-Yin Wong. 更新日期：2021-12-09. 详情 收藏.

Med. Chem. Commun., 2017, 8, 1303-1306 Permissions. Request permissions Benzylsulfanyl benzo-heterocycle amides and hydrazones as new ...

Medicinal Chemistry Communication (Medchemcomm). Publisher: Royal Society of Chemistry. Additional details. Cited half-life, 2.50. Immediacy index, 0.59.

Communications Chemistry is a broad scope open access journal that publishes research across all areas of chemistry.

May 26, 2020 · RSC Med Chem: Vols. 11 to 12; 2020 to 2021 Medchemcomm : Vols. 8 to 10; 2017 to 2019 Articles from this journal are generally available in PMC after a 12-month delay (embargo); however, the delay may vary at the discretion of the publisher.

Cite this: Med. Chem. Commun., 2019, 10,1379 Received 28th May 2019, Accepted 3rd July 2019 DOI: 10.1039/c9md00297a rsc.li/medchemcomm Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia† Xingjian Li, ‡a Daniel T. Payne, ‡a Badarinath Ampolu,§b Nicholas Bland,¶b

Research and review articles in medicinal chemistry and related drug discovery science. MedChemComm has now changed its name to RSC Medicinal Chemistry. Editor-in-chief: Gerhard Ecker<br/>Time to first decision (with reviews): 32 days

2011 2013 2015 2017 2019 Biochemistry Drug Discovery Molecular Medicine Organic Chemistry Pharmaceutical Science Pharmacology. The set of journals have been ...

苄氧羰基（Cbz） 苄氧羰基（Cbz）是1932年Bergmann发现的一个很老的氨基保护基，但一直到今天还在应用。其优点在于：试剂的制备和保护基的导入都比较容易；N-苄氧羰基氨基酸和肽易于结晶而且比较稳定；苄氧羰基氨基酸在活化时不易消旋；能用多种温和的方法选择性地脱去。

Soc., Chem. Commun. View all articles. Journal Information. ISSN / EISSN : 0022-4936 / 2050-5639. Published by: The Royal Society of Chemistry (10.1039).

10.12.2018 · Med. Chem. Commun., 2019, 10, 263-267 Permissions. Request permissions Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors A. Keeley, P. Ábrányi-Balogh and G. M. Keserű, Med ...

d Department of Chemistry of Drugs, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland Abstract Histone acetyltransferases (HATs) are interesting targets for the treatment of cancer and HIV infections but reports on selective inhibitors are very limited.